Controlled release hydrocodone formulations
Published 24 Apr 2014 · application patented
Current assignee: Purdue Pharma L.P. · originally Purdue Pharma
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Benjamin Oshlack, Hua-Pin Huang, Alfred P. Tonelli, John Masselink · Examiner: Sean Basquill · AU 1613 · TC 1600
Life of the application
14 dated eventsAbstract
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C 12 /C max ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
Claims as published
23 claimsLog in to read the claims of this publication.
Log in to unlockClassifications
12 codes- A61K9/28
- A61K9/00
- A61K9/20
- A61K9/16
- A61K31/485
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this publication are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockDocuments
Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.
Log in to unlockChain of title
No assignments have been recorded for this publication yet.